These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 8562412)
41. Megakaryocytes and platelets in myeloproliferative disorders. Briere J; Kiladjian JJ; Peynaud-Debayle E Baillieres Clin Haematol; 1997 Feb; 10(1):65-88. PubMed ID: 9154316 [TBL] [Abstract][Full Text] [Related]
42. Three parameters, plasma thrombopoietin levels, plasma glycocalicin levels and megakaryocyte culture, distinguish between different causes of congenital thrombocytopenia. van den Oudenrijn S; Bruin M; Folman CC; Bussel J; de Haas M; von dem Borne AE Br J Haematol; 2002 May; 117(2):390-8. PubMed ID: 11972523 [TBL] [Abstract][Full Text] [Related]
43. Expression of c-Mpl and c-Mpl ligand gene in hematopoietic cells of individuals with and without myeloproliferative disorders and leukemia cell lines. Sasaki A; Katoh O; Kawaishi K; Hyodo H; Kimura A; Satow Y; Kuramoto A Int J Hematol; 1995 Dec; 62(4):217-23. PubMed ID: 8589367 [TBL] [Abstract][Full Text] [Related]
44. Megakaryocytopoiesis in polycythemia vera: characterization by megakaryocytic progenitors (CFU-Meg) in vitro and quantitation of marrow megakaryocytes. Kimura H; Ohkoshi T; Matsuda S; Uchida T; Kariyone S Acta Haematol; 1988; 79(1):1-6. PubMed ID: 3124455 [TBL] [Abstract][Full Text] [Related]
45. Megakaryocyte progenitors derived from bone marrow or G-CSF-mobilized peripheral blood CD34 cells show a distinct phenotype and responsiveness to interleukin-3 (IL-3) and PEG-recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF). Catani L; Gugliotta L; Campanini E; Mangianti S; Gibellini D; Baravelli S; Vianelli N; Lemoli RM; Tura S Br J Haematol; 1998 Jan; 100(1):207-18. PubMed ID: 9450813 [TBL] [Abstract][Full Text] [Related]
46. MPLW515L is a novel somatic activating mutation in myelofibrosis with myeloid metaplasia. Pikman Y; Lee BH; Mercher T; McDowell E; Ebert BL; Gozo M; Cuker A; Wernig G; Moore S; Galinsky I; DeAngelo DJ; Clark JJ; Lee SJ; Golub TR; Wadleigh M; Gilliland DG; Levine RL PLoS Med; 2006 Jul; 3(7):e270. PubMed ID: 16834459 [TBL] [Abstract][Full Text] [Related]
47. Coexpression of thrombopoietin and c-mpl genes in human acute myeloblastic leukemia cells. Matsumura I; Kanakura Y; Ikeda H; Ishikawa J; Yoshida H; Horikawa Y; Nishiura T; Tahara T; Kato T; Miyazaki H; Matsuzawa Y Leukemia; 1996 Jan; 10(1):91-4. PubMed ID: 8558944 [TBL] [Abstract][Full Text] [Related]
48. Marked heterogeneity in protein levels and functional integrity of the thrombopoietin receptor c-mpl in polycythaemia vera. Le Blanc K; Andersson P; Samuelsson J Br J Haematol; 2000 Jan; 108(1):80-5. PubMed ID: 10651727 [TBL] [Abstract][Full Text] [Related]
49. [Thrombopoietin and megakaryocyte differentiation]. Vainchenker W; Debili N; Norol F; Wendling F Schweiz Med Wochenschr; 1998 Oct; 128(42):1575-81. PubMed ID: 9824885 [TBL] [Abstract][Full Text] [Related]
50. Megakaryocytopoiesis in vitro: from the stem cells' perspective. Cardier JE; Foster DC; Lok S; Jacobsen SE; Murphy MJ Stem Cells; 1996; 14 Suppl 1():163-72. PubMed ID: 11012217 [TBL] [Abstract][Full Text] [Related]
51. Phorbol ester PMA induces expression of the thrombopoietin receptor MPL in leukemia cells. Graf G; Zaborski M; Quentmeier H; Drexler HG Leuk Lymphoma; 1996 Dec; 24(1-2):149-57. PubMed ID: 9049971 [TBL] [Abstract][Full Text] [Related]
52. Glycoprotein 130 and c-kit signals synergistically induce thrombopoietin production by hematopoietic cells. Matsui A; Sato T; Maekawa T; Asano S; Nakahata T; Tsuji K Int J Hematol; 2000 Dec; 72(4):455-62. PubMed ID: 11197211 [TBL] [Abstract][Full Text] [Related]
53. Cloning and functional characterization of a novel c-mpl variant expressed in human CD34 cells and platelets. Li J; Sabath DF; Kuter DJ Cytokine; 2000 Jul; 12(7):835-44. PubMed ID: 10880227 [TBL] [Abstract][Full Text] [Related]
54. Thrombopoietin stimulates VEGF release from c-Mpl-expressing cell lines and haematopoietic progenitors. Bobik R; Hong Y; Breier G; Martin JF; Erusalimsky JD FEBS Lett; 1998 Feb; 423(1):10-4. PubMed ID: 9506832 [TBL] [Abstract][Full Text] [Related]
55. Elevated thrombopoietin levels in patients with myelofibrosis may not be due to enhanced production of thrombopoietin by bone marrow. Wang JC; Hashmi G Leuk Res; 2003 Jan; 27(1):13-7. PubMed ID: 12479847 [TBL] [Abstract][Full Text] [Related]
56. The role of the MPL receptor in myeloproliferative disorders. Kaushansky K Leukemia; 1998 Sep; 12 Suppl 1():S47-50. PubMed ID: 9777896 [TBL] [Abstract][Full Text] [Related]
57. [Significance of thrombopoietin and its receptor c-Mpl in regulation of thrombocytopoiesis in thrombocytopenia]. Strauss G; Ballmaier M; Schulze H; Bogenberger J; Riehm H; Welte K Klin Padiatr; 1996; 208(4):168-71. PubMed ID: 8926683 [TBL] [Abstract][Full Text] [Related]
58. c-mpl mutations are the cause of congenital amegakaryocytic thrombocytopenia. Ballmaier M; Germeshausen M; Schulze H; Cherkaoui K; Lang S; Gaudig A; Krukemeier S; Eilers M; Strauss G; Welte K Blood; 2001 Jan; 97(1):139-46. PubMed ID: 11133753 [TBL] [Abstract][Full Text] [Related]
59. [Dysmegakaryocytopoiesis and dysthrombopoiesis in myeloproliferative syndromes]. Brière J; Kiladjian JJ; Peynaud-Debayle E C R Seances Soc Biol Fil; 1996; 190(5-6):533-9. PubMed ID: 9074718 [TBL] [Abstract][Full Text] [Related]
60. Analysis of megakaryocyte growth and development factor (thrombopoietin) effects on blast cell and megakaryocyte growth in myelodysplasia. Fontenay-Roupie M; Dupont JM; Picard F; Fichelson S; Botella A; Melle J; Guesnu M; Casadevall N; Dreyfus F; Bouscary D Leuk Res; 1998 Jun; 22(6):527-35. PubMed ID: 9678719 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]